N. Moreau

发表

Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum.

V. Jarlier, W. Sougakoff, E. Cambau, 1999, Microbiology.

Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.

L. Gutmann, M. Kitzis, F. Goldstein, 1985, The Journal of infectious diseases.

Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific Therapy against Pseudomonas aeruginosa.

M. Abdallah, J. Desnottes, J. Paris, 2001, Journal of medicinal chemistry.

Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.

S. Houot, E. Bergogne-Bérézin, M. Joly-Guillou, 1996, The Journal of antimicrobial chemotherapy.

Surface‐enhanced raman spectroscopy investigation of fluoroquinolone/DNA/DNA gyrase/Mg2+ interactions: Part I. Adsorption of pefloxacin on colloidal silver—effect of drug concentration, electrolytes, and pH

M. Manfait, S. Lecomte, J. Aubard, 1995 .

Synthesis and antibiotic activity of a small molecules library of 1,2,3-triazole derivatives.

J. Herscovici, P. Bouhours, N. Moreau, 2008, Bioorganic & medicinal chemistry letters.

Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae

L. Gutmann, M. Kitzis, C. Janoir, 1997, Antimicrobial agents and chemotherapy.

Resistance to fluoroquinolones in Escherichia coli isolated from poultry

L. Gutmann, X. Y. Zhou, N. Moreau, 1996, Antimicrobial agents and chemotherapy.

Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones

N., N. Moreau, S. Bazile, 1992, Antimicrobial Agents and Chemotherapy.

A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics

L. Gutmann, J. Nguyen Van, D. Shlaes, 1997, Antimicrobial agents and chemotherapy.

NMR investigation of pefloxacin-cation-DNA interactions: the essential role of Mg2+

S. Lecomte, N. Moreau, M. Chenon, 1998 .

Anti-bacterial activity of some Brazilian medicinal plants.

A. F. Dos Santos, A. Sant'Ana, L. Neuville, 2006, Journal of ethnopharmacology.

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid

L. Gutmann, J. Acar, N. Moreau, 1991, Antimicrobial Agents and Chemotherapy.

Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis

V. Jarlier, W. Sougakoff, V. Revel-Viravau, 1996, Antimicrobial agents and chemotherapy.

Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.

Lionel Joucla, M. Lemaire, B. Marquez, 2007, Bioorganic & medicinal chemistry.

Role of the 1-amino group in aminocyclitol antibiotics: synthesis of 1-deaminogentamicin C2.

P. Stütz, H. Loibner, B. Quiclet-Sire, 1983, The Journal of antibiotics.

Effect of magnesium complexation by fluoroquinolones on their antibacterial properties

S. Lecomte, N. Moreau, M. Chenon, 1994, Antimicrobial Agents and Chemotherapy.

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II

N. Moreau, X. Tabary, H. Robaux, 1990, Antimicrobial Agents and Chemotherapy.

properties. on their antibacterial Effect of magnesium complexation by

S. Lecomte, N. Moreau, M. Chenon, 2013 .

Multidrug resistance reversal agent from Jatropha elliptica.

A. F. Dos Santos, A. Sant'ana, L. Neuville, 2005, Phytochemistry.

Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I

N. Moreau, C. Dureuil, F. Le Goffic, 1987, Antimicrobial Agents and Chemotherapy.

Metabolism of oltipraz and glutathione reductase inhibition.

J. Leroy, T. Martens, M. Fleury, 1990, Biochemical Pharmacology.

[Current status of resistance of bacteria to pefloxacin in hospital units. Cross resistance with ofloxacin and ciprofloxacin. Results of a multicenter study].

P. Dellamonica, N. Moreau, A. Thabaut, 1994, Pathologie-biologie.

High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA

L. Gutmann, M. Kitzis, L Gutmann, 1996, Antimicrobial agents and chemotherapy.

Influence of sub-inhibitory concentrations of antibacterials on the surface properties and adhesion of Escherichia coli.

J. Desnottes, N. Moreau, C. Loubeyre, 1993, The Journal of antimicrobial chemotherapy.

Interactions between fluoroquinolones, Mg2+, DNA and DNA gyrase, studied by phase partitioning in an aqueous two-phase system and by affinity chromatography.

N. Moreau, S. B. Khac, 1994, Journal of chromatography. A.

Molecular cloning and analysis of Staphylococcus aureus chromosomal aminoglycoside resistance genes.

S. Ehrlich, N. Solh, N. Moreau, 1986, Plasmid.

Kinetic studies of aminoglycoside acetyltransferase and phosphotransferase from Staphylococcus aureus RPAL. Relationship between the two activities.

M. Másson, A. Martel, N. Moreau, 1983, European journal of biochemistry.

Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition.

N. Moreau, A. Denis, 1993, Journal of Antimicrobial Chemotherapy.

Effect of pefloxacin on microorganism: host cell interaction.

J. Desnottes, N. Moreau, N. Diallo, 1990, The Journal of antimicrobial chemotherapy.

Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy.

D. Hooper, C. Soussy, N. Moreau, 1995, The Journal of antimicrobial chemotherapy.